Information Security Service and Project Manager at Acadia Pharmaceuticals

Lisbon, Lisbon, Portugal

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Relevant professional training, certifications, or demonstrated job experience in Information Security and Project Management
Strong knowledge and hands-on experience with core Information Security principles and practices
Strong background in managing cross-functional projects
Proven experience in service and supplier management
Experience applying information security standards; knowledge of ISO 27001 and NIST is welcomed but not required
Expertise in KPI-based performance management
Experience managing external services
Strong communication skills in English, both written and spoken
Background in pharma or other regulated industries is considered a valuable asset

Responsibilities

Driving KPI-based performance management for internal and outsourced security activities
Leading and coordinating information security projects
Facilitating collaboration between Principal Security Architects, consultants, and cross-functional IT teams
Partnering with IT application teams to ensure compliance with InfoSec standards
Managing relationships with key security vendors and service providers
Acting as a facilitator to remove obstacles and connect the right people to the right initiatives
Supporting governance processes to prioritize ongoing InfoSec activities

Skills

Information Security

Project Management

Security Architecture

IT Operations

Vendor Management

KPI Management

Stakeholder Collaboration

IT Governance

Compliance

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free